Betadine

Manufacturer
Rebel Distributors Corp
Effective date
2011-10-25
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:13:26

Label at a glance#

ProductBetadine
Active ingredientPOVIDONE-IODINE
Label structure12 sections

Indications and uses

BETADINE® 5% Sterile Ophthalmic Prep Solution for the eye is indicated for prepping of the periocular region (lids, brow, and cheek) and irrigation of the ocular surface (cornea, conjunctiva, and palpebral fornices).

Dosage and administration

While the inner surface and contents of the immediate container (i.e. bottle) are sterile, the outer surface of the bottle is not sterile. The use of the bottle in a sterile field should be avoided. BETADINE® 5% Sterile Ophthalmic Prep Solution is used as follows: 1. Make sure container is intact before use. To open, COMPLETELY TWIST OFF TAB, do not pull off. Gently squeeze entire contents of bottle into a sterile...

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Povidone-Iodine is a broad-spectrum microbicide with the chemical formulas:

2-pyrrolidinone, 1- ethenyl-, homopolymer, compound with iodine; 1-vinyl-2-pyrrolidinone polymer, compound with iodine. The structural formula is as follows:

chemical
chemical

BETADINE® 5% Sterile Ophthalmic Prep Solution contains 5% povidone-iodine (0.5% available iodine) as a sterile dark brown solution stabilized by glycerin. Inactive Ingredients: citric acid, glycerin, nonoxynol-9, sodium chloride, sodium hydroxide, and dibasic sodium phosphate.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

A placebo-controlled study in 38 normal volunteers yielded data for 36 subjects who showed a mean log10 reduction of 3.05 log10 units in total aerobes at 10 minutes following prepping the skin with BETADINE® 5% Sterile Ophthalmic Prep Solution compared with reduction of 1.58 log10 units after prepping with vehicle free of the iodine complex. This placebo-controlled study indicates a mean log10 reduction by the iodine complex compared with the control solution of 1.47 log10 units at 10 minutes and 1.79 log10 units at 45 minutes. The base-line mean aerobic bacterial count was 7,586 organisms per square cm.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

BETADINE® 5% Sterile Ophthalmic Prep Solution for the eye is indicated for prepping of the periocular region (lids, brow, and cheek) and irrigation of the ocular surface (cornea, conjunctiva, and palpebral fornices).

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Do not use on individuals known to be sensitive to iodine, or other components of this product.

WARNINGS

WARNINGS SECTION

FOR EXTERNAL USE ONLY. NOT FOR INTRAOCULAR INJECTION OR IRRIGATION.

PRECAUTIONS:

PRECAUTIONS SECTION

General

GENERAL PRECAUTIONS SECTION

No studies are available in patients with thyroid disorders; therefore, caution is advised in using BETADINE® 5% Sterile Ophthalmic Prep Solution in these patients due to the possibility of iodine absorption.

Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

No long term studies in animals have been performed to evaluate the carcinogenic or mutagenic potential of povidone-iodine. One report of the mutagenic potential of povidone-iodine indicated that it was positive in a modification of the Ames S. typhimurium model, but these results could not be reproduced by another researcher. Another test using mouse lymphoma and Balb/3T3 cells showed that povidone-iodine has no significant mutagenic or transformation capabilities. Other data indicated that it does not produce mutagenic effects in mice or hamsters according to the dominant lethal test, micronucleus test, and chromosome analysis.

Pregnancy

PREGNANCY SECTION

Category C: Animal reproduction studies have not been conducted with BETADINE® 5% Sterile Ophthalmic Prep Solution. It is also not known whether BETADINE® 5% Sterile Ophthalmic Prep Solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. BETADINE® 5% Sterile Ophthalmic Prep Solution should only be used on a pregnant woman if clearly needed.

Nursing Mothers

NURSING MOTHERS SECTION

Because of the potential for serious adverse reactions in nursing infants from BETADINE® 5% Sterile Ophthalmic Prep Solution, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in pediatric patients have not been established.

Geriatric Use

GERIATRIC USE SECTION

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Local sensitivity has been exhibited by some individuals to povidone-iodine ophthalmic solution.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

While the inner surface and contents of the immediate container (i.e. bottle) are sterile, the outer surface of the bottle is not sterile. The use of the bottle in a sterile field should be avoided.

BETADINE® 5% Sterile Ophthalmic Prep Solution is used as

follows:

1. Make sure container is intact before use. To open, COMPLETELY TWIST OFF TAB, do not pull off. Gently squeeze entire contents of bottle into a sterile prep cup.

2. Saturate sterile cotton-tipped applicator to prep lashes and lid margins using one or more applicators per lid; repeat once.

3. Saturate sterile prep sponge or other suitable material to prep lids, brow and cheek in a circular ever-expanding fashion until the entire field is covered; repeat prep three (3) times.

4. While separating the lids, irrigate the cornea, conjunctiva and palpebral fornices with BETADINE® 5% Sterile Ophthalmic Prep Solution using a sterile bulb syringe.

5. After the BETADINE® 5% Sterile Ophthalmic Prep Solution has been left in contact for two minutes, sterile saline solution in a bulb syringe should be used to flush the residual prep solution from the cornea, conjunctiva, and the palpebral fornices.

HOW SUPPLIED

HOW SUPPLIED SECTION

BETADINE® 5% Sterile Ophthalmic Prep Solution is packaged under sterile conditions and supplied in 1 fl.oz. (30 mL) form sealed blue HDPE bottles (NDC #42254-006-30).

Store at 15-25°C (59-77°F).

Rx Only

Single use only

       

Manufactured for:

Alcon Laboratories, Inc.

Fort Worth, TX 76134

        

Manufactured by:

Catalent Pharma Solutions, LLC

Woodstock, IL 60098

Relabeled by:

Rebel Distributors Corp

Thousand Oaks, CA 91320

      

BETADINE® is a registered trademark of The Purdue Frederick Company.

       

9002984-1007

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 42254-006-30

Betadine® 5%

Sterile Ophthalmic Prep Solution

(povidone-iodine

ophthalmic solution)

For Pre-Operative Prep and

Irrigation of the Ocular and

Periocular Surfaces

Flush eye thoroughly with

sterile saline solution after

each use.

Rx Only

1 Fl. Oz. (30 mL)

Betadine 5%
Betadine 5%

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1149663Betadine 5 % Ophthalmic SolutionPSN1
312570povidone-iodine 5 % Ophthalmic SolutionPSN1
1149663povidone-iodine 50 MG/ML Ophthalmic Solution [Betadine]SBD1
312570povidone-iodine 50 MG/ML Ophthalmic SolutionSCD1
1149663Betadine 50 MG/ML Ophthalmic SolutionSY1
1149663Betadine Ophthalmic Prep 5 % Ophthalmic SolutionSY1
312570povidone-iodine 5 % Ophthalmic SolutionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5f30b278-5791-4113-8781-878a9221ef8aProduct name220230125
2a70c781-a755-4d76-b20a-a958acfbdcdcProduct name220190619
304592ef-4a8a-4c22-8e8c-af73aa3d60e5Product name120180703
ac0821a1-ce75-4ea7-880a-59eecaecdf22Product name120180703
db5dc4f9-b907-46f6-8fb7-babcf04bbe5cProduct name120180619
41e9d6cf-3ed7-4c44-a57e-0685058d0896Product name120170824
5e652c92-68fd-426b-b0e7-5fc64e0b9f99Product name120170309
ddc0c11a-bba8-408f-b3c7-c4828b4bcc8cProduct name120150421

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
42254-006-30Betadine30 mL in 1 BOTTLESOLUTION301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
42254-006BETADINE (POVIDONE-IODINE) SOLUTION [REBEL DISTRIBUTORS CORP]1Legacy NDC, 1 package rows20111208_72287bb4-3f70-4e12-aaf3-cfff48e044f8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
42254-006-30ML - Milliliter42254-00603bbbee9-f195-42e3-b4e5-37c79140e46b12012-07-24
0065-0411-30ML - Milliliter0065-04112a70d730-f5e2-47f6-9b09-60ed0ed617b612012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
POVIDONE-IODINEACTIVE INGREDIENT85H0HZU99M1
IODINEACTIVE MOIETY9679TC07X41
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QP1
GLYCERININACTIVE INGREDIENTPDC6A3C0OX1
NONOXYNOL-9INACTIVE INGREDIENT48Q180SH9T1
SODIUM CHLORIDEINACTIVE INGREDIENT451W47IQ8X1
SODIUM HYDROXIDEINACTIVE INGREDIENT55X04QC32I1
SODIUM PHOSPHATE, DIBASICINACTIVE INGREDIENTGR686LBA741

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
42254-00642254-006-30
0065-0411

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 7 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
SODIUM PHOSPHATE, DIBASICSODIUM PHOSPHATE, DIBASICGR686LBA74SOLUTION / ORAL40 mg/1mlExact identifier — unii+dosage form
2 equally ranked IID candidates
SODIUM HYDROXIDESODIUM HYDROXIDE55X04QC32ISOLUTION / OPHTHALMIC0.05 %w/vExact identifier — unii+route+dosage form
SODIUM CHLORIDESODIUM CHLORIDE451W47IQ8XSOLUTION / OPHTHALMIC13 mgExact identifier — unii+route+dosage form
SODIUM PHOSPHATE, DIBASICSODIUM PHOSPHATE, DIBASICGR686LBA74SUSPENSION / OPHTHALMIC0.43 %w/wExact identifier — unii+route
2 equally ranked IID candidates
CITRIC ACID MONOHYDRATECITRIC ACID MONOHYDRATE2968PHW8QPSOLUTION / OPHTHALMIC0.03 %w/vExact identifier — unii+route+dosage form
NONOXYNOL-9NONOXYNOL-948Q180SH9TSOLUTION / OPHTHALMIC0.13 %w/wExact identifier — unii+route+dosage form
GLYCERINGLYCERINPDC6A3C0OXSOLUTION / OPHTHALMIC6 %w/vExact identifier — unii+route+dosage form

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N018634-001BETADINEPOVIDONE-IODINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-1784e616aacf4f…
2026-08-18 06:07:402026-07N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-1774a2ff9319b5…
2022-03-09 01:35 UTC2022-03N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-1787673890dc5c…
2021-03-12 10:30 UTC2021-03N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-175aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-178869cabd3fbd…
2020-11-12 02:37 UTC2020-11N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17c0c555d07b60…
2019-12-14 00:12 UTC2019-12N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-173f01610625f2…
2019-09-15 20:21 UTC2019-09N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17b00525d2431f…
2019-07-19 19:46 UTC2019-07N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-176a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-171c564ffb4f44…
2023-12-20 04:57 UTC2023-12N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-179b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-173f0d92c62455…
2023-05-13 08:27 UTC2023-05N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17053a50430f4f…
2023-01-26 05:58 UTC2023-01N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-173bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-173a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N018634-001BETADINE5%SOLUTION/DROPS / OPHTHALMICRLD, RS1986-12-17f41ea6bd6efb…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BetadinePOVIDONE-IODINEAlcon Laboratories, Inc.b026de1b-9949-4557-ac49-c7b0038c24cd2022-06-29Warnings, Adverse reactionsExact identifier
ndc (product): 0065-0411
72287bb4-3f70-4e12-aaf3-cfff48e044f872287bb4-3f70-4e12-aaf3-cfff48e044f82011-10-25Warnings, Adverse reactionsExact identifier
spl id: 72287bb4-3f70-4e12-aaf3-cfff48e044f8
spl set id: 72287bb4-3f70-4e12-aaf3-cfff48e044f8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.